{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:02:40Z","timestamp":1776402160508,"version":"3.51.2"},"reference-count":40,"publisher":"Elsevier","isbn-type":[{"value":"9780443296147","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006251","name":"Universit\u00e9 de Bordeaux","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006251","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019164","name":"Fondation Toulouse Cancer Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019164","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["UMR 5164"],"award-info":[{"award-number":["UMR 5164"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.mcb.2025.05.004","type":"book-chapter","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T21:49:13Z","timestamp":1749160153000},"page":"23-38","source":"Crossref","is-referenced-by-count":1,"title":["A syngeneic orthotopic mouse model of metastatic colorectal cancer"],"prefix":"10.1016","author":[{"given":"Virginie","family":"Feliu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Ayyoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Devaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/bs.mcb.2025.05.004_bib1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41571-020-00445-1","article-title":"Rising incidence of early-onset colorectal cancer - a call to action","volume":"18","author":"Akimoto","year":"2021","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"23","key":"10.1016\/bs.mcb.2025.05.004_bib2","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability\u2013high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/bs.mcb.2025.05.004_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s42826-021-00096-y","article-title":"Induction of colorectal carcinogenesis in the C57BL\/6J and A\/J mouse strains with a reduced DSS dose in the AOM\/DSS model","volume":"37","author":"Arnesen","year":"2021","journal-title":"Laboratory Animal Research"},{"issue":"7165","key":"10.1016\/bs.mcb.2025.05.004_bib4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nature06196","article-title":"Identification of stem cells in small intestine and colon by marker gene Lgr5","volume":"449","author":"Barker","year":"2007","journal-title":"Nature"},{"issue":"7229","key":"10.1016\/bs.mcb.2025.05.004_bib5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nature07602","article-title":"Crypt stem cells as the cells-of-origin of intestinal cancer","volume":"457","author":"Barker","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.mcb.2025.05.004_bib6","first-page":"9","article-title":"Molecular genetics of colorectal cancer","volume":"27","author":"Bogaert","year":"2014","journal-title":"Annals of Gastroenterology"},{"issue":"13","key":"10.1016\/bs.mcb.2025.05.004_bib7","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3748\/wjg.v26.i13.1394","article-title":"Mouse models of colorectal cancer: Past, present and future perspectives","volume":"26","author":"B\u00fcrtin","year":"2020","journal-title":"World Journal of Gastroenterology"},{"issue":"15","key":"10.1016\/bs.mcb.2025.05.004_bib8","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1158\/0008-5472.CAN-15-0727","article-title":"Maintaining tumor heterogeneity in patient-derived tumor xenografts","volume":"75","author":"Cassidy","year":"2015","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/bs.mcb.2025.05.004_bib9","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2353\/ajpath.2007.060773","article-title":"Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites","volume":"170","author":"C\u00e9spedes","year":"2007","journal-title":"The American Journal of Pathology"},{"issue":"11","key":"10.1016\/bs.mcb.2025.05.004_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109956","article-title":"\u201cGlowing Head\u201d mice: A genetic tool enabling reliable preclinical image-based evaluation of cancers in immunocompetent allografts","volume":"9","author":"Day","year":"2014","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/bs.mcb.2025.05.004_bib11","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1158\/0008-5472.CAN-08-3037","article-title":"Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model","volume":"69","author":"Devaud","year":"2009","journal-title":"Cancer Research"},{"issue":"7","key":"10.1016\/bs.mcb.2025.05.004_bib12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00262-013-1402-1","article-title":"Anti-metastatic potential of human V\u03b41(+) \u03b3\u03b4 T cells in an orthotopic mouse xenograft model of colon carcinoma","volume":"62","author":"Devaud","year":"2013","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"issue":"1","key":"10.1016\/bs.mcb.2025.05.004_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/mt.2013.219","article-title":"Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy","volume":"22","author":"Devaud","year":"2014","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.mcb.2025.05.004_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.32120","article-title":"FAK alternative splice mRNA variants expression pattern in colorectal cancer","author":"Devaud","year":"2019","journal-title":"International Journal of Cancer [Preprint]"},{"issue":"1","key":"10.1016\/bs.mcb.2025.05.004_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41467-017-02424-0","article-title":"Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution","volume":"9","author":"Efremova","year":"2018","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/bs.mcb.2025.05.004_bib16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1470-2045(19)30027-0","article-title":"Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): A multicentre, open-label, phase 3, randomised, controlled trial","volume":"20","author":"Eng","year":"2019","journal-title":"The Lancet Oncology"},{"issue":"84","key":"10.1016\/bs.mcb.2025.05.004_bib17","doi-asserted-by":"crossref","first-page":"eadg8841","DOI":"10.1126\/sciimmunol.adg8841","article-title":"Distant antimetastatic effect of enterotropic colon cancer-derived \u03b14\u03b27+CD8+ T cells","volume":"8","author":"Feliu","year":"2023","journal-title":"Science Immunology"},{"issue":"20","key":"10.1016\/bs.mcb.2025.05.004_bib18","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.88.20.9345","article-title":"Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens","volume":"88","author":"Fu","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.mcb.2025.05.004_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.coi.2013.03.008","article-title":"Cancer immunotherapy","volume":"25","author":"Gajewski","year":"2013","journal-title":"Current Opinion in Immunology"},{"issue":"11","key":"10.1016\/bs.mcb.2025.05.004_bib20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/bs.mcb.2025.05.004_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/PPO.0000000000000439","article-title":"Oligometastatic disease and local therapies: A medical oncology perspective","volume":"26","author":"Hafez","year":"2020","journal-title":"Cancer Journal (Sudbury, Mass.)"},{"issue":"6","key":"10.1016\/bs.mcb.2025.05.004_bib22","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1053\/j.gastro.2010.01.054","article-title":"Hereditary and familial colon cancer","volume":"138","author":"Jasperson","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/bs.mcb.2025.05.004_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.15252\/emmm.201606857","article-title":"Genetically engineered mouse models in oncology research and cancer medicine","volume":"9","author":"Kersten","year":"2017","journal-title":"EMBO Molecular Medicine"},{"issue":"1","key":"10.1016\/bs.mcb.2025.05.004_bib24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1186\/s12885-016-2879-8","article-title":"Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt\/\u03b2-catenin signaling in CD133+ human colorectal cancer cells","volume":"16","author":"Klose","year":"2016","journal-title":"BMC Cancer"},{"issue":"6349","key":"10.1016\/bs.mcb.2025.05.004_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.mcb.2025.05.004_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.dnarep.2015.11.015","article-title":"Mouse models of DNA mismatch repair in cancer research","volume":"38","author":"Lee","year":"2016","journal-title":"DNA Repair"},{"issue":"4","key":"10.1016\/bs.mcb.2025.05.004_bib27","first-page":"227","article-title":"Tumors of the alimentary tract induced in mice by feeding olive-oil emulsions containing carcinogenic hydrocarbons","volume":"7","author":"Lorenz","year":"1947","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"10.1016\/bs.mcb.2025.05.004_bib28","first-page":"363","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"16","key":"10.1016\/bs.mcb.2025.05.004_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/vr.116.16.431","article-title":"Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment","volume":"116","author":"Morton","year":"1985","journal-title":"The Veterinary Record"},{"issue":"4940","key":"10.1016\/bs.mcb.2025.05.004_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1126\/science.2296722","article-title":"A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse","volume":"247","author":"Moser","year":"1990","journal-title":"Science (New York, N. Y.)"},{"issue":"9","key":"10.1016\/bs.mcb.2025.05.004_bib31","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.3390\/cancers15092570","article-title":"Experimental murine models for colorectal cancer research","volume":"15","author":"Neto","year":"2023","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/bs.mcb.2025.05.004_bib32","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.2007.14.9930","article-title":"Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study","volume":"26","author":"Saltz","year":"2008","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"3","key":"10.1016\/bs.mcb.2025.05.004_bib33","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","article-title":"Colorectal cancer in inflammatory bowel disease: Mechanisms and management","volume":"162","author":"Shah","year":"2022","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/bs.mcb.2025.05.004_bib34","first-page":"145","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"10","key":"10.1016\/bs.mcb.2025.05.004_bib35","first-page":"2032","article-title":"Synergistic anticancer activity of a novel oral chemotherapeutic agent containing trifluridine and tipiracil in combination with anti-PD-1 blockade in microsatellite stable-type murine colorectal cancer cells","volume":"7","author":"Suzuki","year":"2017","journal-title":"American Journal of Cancer Research"},{"issue":"26","key":"10.1016\/bs.mcb.2025.05.004_bib36","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.mcb.2025.05.004_bib37","first-page":"44","article-title":"The moribund state as an experimental endpoint","volume":"36","author":"Toth","year":"1997","journal-title":"Contemporary Topics in Laboratory Animal Science"},{"issue":"1","key":"10.1016\/bs.mcb.2025.05.004_bib38","doi-asserted-by":"crossref","first-page":"1790125","DOI":"10.1080\/2162402X.2020.1790125","article-title":"Colon-specific immune microenvironment regulates cancer progression versus rejection","volume":"9","author":"Trimaglio","year":"2020","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/bs.mcb.2025.05.004_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/bs.mcb.2025.05.004_bib40","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc.2016.91","article-title":"Mouse models in oncoimmunology","volume":"16","author":"Zitvogel","year":"2016","journal-title":"Nature Reviews. Cancer"}],"container-title":["Methods in Cell Biology","Immuno-Oncology and Immunotherapy - Part F"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X25001323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X25001323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:01:44Z","timestamp":1769677304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091679X25001323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443296147"],"references-count":40,"URL":"https:\/\/doi.org\/10.1016\/bs.mcb.2025.05.004","relation":{},"ISSN":["0091-679X"],"issn-type":[{"value":"0091-679X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}